Advertisement

Topics

Biologic GmbH & Co KG Company Profile

18:36 EST 14th December 2018 | BioPortfolio

Biologic beschäftigt sich mit der Entwicklung von biotechnologischen Produkten und Verfahren für den Umweltschutz bis zur technischen Marktreife mit entsprechendem Marketingkonzept. Nach erwiesener Akzeptanz des Marktes erfolgen Herstellung und Vertrieb durch Fachfirmen als Lizenzpartner. Die Kernkompetenz besteht in allem was mit dem biologischen Abbau durch Mikroorganismen zu tun hat. Dabei reicht die Produktpalette von einem biologischen Verfahren zur Entschlammung und Sanierung von Flachgewässern (Pond), über den Bio-Filterdeckel für Müllgefäße bis hin zu einer biologisch wirkenden Schuheinlage (Bioletta) gegen Fußgeruch und Fußpilz.

Location

Gildenstraße 18
Münster
48157
Germany

Contact

Phone: (+49) 0251 23948-0
Fax: (+49) 0251 23948-16
Email: info@biologic.de


News Articles [360 Associated News Articles listed on BioPortfolio]

Preparing for the big biologic switch

With blockbuster biologic adalimumab coming off patent in October 2018, pharmacists should be ready to switch patients to the best value biologic as alternatives become available.

Making the switch — preparing for the patent expiry of the NHS's most costly biologic

With blockbuster biologic adalimumab coming off patent in October 2018, pharmacists should be ready to switch patients to the best value biologic as alternatives become available.

China Biologic Receives Non-Binding Acquisition Proposal

NewsCITIC Capital proposes to acquire all of the outstanding shares of China Biologic that are not already owned by CITIC for $110 in cash per share, an estimated $3.7 billion.

Precision BioLogic Acquires Affinity Biologicals

NewsPrecision BioLogic Inc. has completed the acquisition of Affinity Biologicals Inc., a manufacturer of reagents and kits used in hemostasis and thrombosis research and diagnostics.

New financing round at oncgnostics GmbH close

The life sciences company oncgnostics GmbH was able to double its investment of 750,000 euros following the very rapid and successful completion of its second crowd investing campaign on Seedmatch. A...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

BioRad BioLogic HR Low Pressure LP Chromatography Workstation +More

$1,495.00End Date: Friday Aug-24-2018 20:03:59 PDTBuy It Now for only: $1,495.00Buy It Now | Add to watch list Biotech365 : BioRad BioLogic HR Low Pressure LP Chromatography Workstation +More Bio...

Bio-Rad Biologic PR 3100 TSC Microplate Reader (15347)

$399.95End Date: Sunday Jul-22-2018 12:36:09 PDTBuy It Now for only: $399.95Buy It Now | Add to watch list Biotech365 : Bio-Rad Biologic PR 3100 TSC Microplate Reader (15347) BioMarketplace You w...

PubMed Articles [205 Associated PubMed Articles listed on BioPortfolio]

Incidence of Infectious Adverse Events in Patients With Rheumatoid Arthritis and Spondyloarthritis on Biologic Drugs-Data From the Brazilian Registry for Biologics Monitoring.

The safety profile of biologic drugs might present substantial regional differences. Since 2009, the Brazilian Society of Rheumatology has maintained BIOBADABRASIL (Brazilian Registry for Biologic Dru...

A Current Review of Biologic Meshes in Abdominal Wall Reconstruction.

It is well accepted that the use of mesh has facilitated and improved outcomes following repair of the complex abdominal hernias. Current mesh options include biologic, synthetic, and resorbable mater...

Cost of biologic treatment persistence or switching in rheumatoid arthritis.

To estimate total costs among patients with rheumatoid arthritis (RA) who persisted on or switched from newly initiated biologic therapy.

Two-year adherence and costs for biologic therapy for rheumatoid arthritis.

To evaluate adherence to newly initiated biologic disease-modifying antirheumatic drugs (bDMARDs) in effectively treated patients with rheumatoid arthritis (RA).

The frequency of infections in patients with juvenile idiopathic arthritis on biologic agents: 1-year prospective study.

The most effective and concurrently the safest treatment regimen selection is important to provide early control of juvenile idiopathic arthritis (JIA) and to have an acceptable quality of life. The e...

Clinical Trials [535 Associated Clinical Trials listed on BioPortfolio]

Retrospective Analysis of Pulmonary Arterial Hypertension (PAH) and Related Complications in Juvenile Idiopathic Arthritis (JIA) Participants Treated With Biologic and Non-biologic Disease-modifying Anti-rheumatic Drugs (DMARDs)

This study is designed to analyze the frequency and incidence rate of pulmonary complications in JIA participants who received biological DMARDs and non-biologic DMARDs. The participants h...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

A Biologic Joint Replacement Strategy for Knee Trauma and Post-Traumatic Osteoarthritis

Participants will be enrolled in a prospective clinical trial to assess outcomes in 2 cohorts of patients undergoing unicompartmental versus more extensive biologic OCA transplantation of ...

Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic Therapy

That anti-TNF therapy and rituximab therapy are equally effective in treating patients with rheumatoid arthritis who meet the eligibility criteria for biologic therapy in the British Socie...

Performance of Biologic Mesh Materials in Abdominal Wall Reconstruction

To date, there have been no prospective randomized controlled trials that compare various biologic mesh materials in the context of abdominal wall reconstruction. As a result, this proposa...

Companies [644 Associated Companies listed on BioPortfolio]

Biologic GmbH & Co KG

Biologic beschäftigt sich mit der Entwicklung von biotechnologischen Produkten und Verfahren für den Umweltschutz bis zur technischen Marktreife mit entsprechendem Marketingkonzept. Nach erwiesener ...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

China Biologic Products, Inc.

China Biologic Products, Inc. (the "Company"), through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd, and...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

BioLogic Company

BioLogic grows, formulates, and sells, natural insect parasites and pathogens of pests. Our natural biocontrol products for horticulture, home, lawn, garden, and greenhouse kill insect pests, but are ...

More Information about "Biologic GmbH & Co KG" on BioPortfolio

We have published hundreds of Biologic GmbH & Co KG news stories on BioPortfolio along with dozens of Biologic GmbH & Co KG Clinical Trials and PubMed Articles about Biologic GmbH & Co KG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biologic GmbH & Co KG Companies in our database. You can also find out about relevant Biologic GmbH & Co KG Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record